EI9 Stock Overview
Elos Medtech AB (publ) engages in the development and contract manufacturing of medical devices and components for dental, orthopedics, diagnostics, and hearing and other medical device markets. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Elos Medtech AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 17.85 |
| 52 Week High | SEK 25.40 |
| 52 Week Low | SEK 15.95 |
| Beta | 1.12 |
| 11 Month Change | -1.92% |
| 3 Month Change | -0.56% |
| 1 Year Change | -19.59% |
| 33 Year Change | 75.86% |
| 5 Year Change | n/a |
| Change since IPO | 158.70% |
Recent News & Updates
Recent updates
Shareholder Returns
| EI9 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 2.6% | -1.0% | -0.02% |
| 1Y | -19.6% | -7.3% | 8.2% |
Return vs Industry: EI9 underperformed the German Medical Equipment industry which returned 9.4% over the past year.
Return vs Market: EI9 underperformed the German Market which returned 8.5% over the past year.
Price Volatility
| EI9 volatility | |
|---|---|
| EI9 Average Weekly Movement | 4.5% |
| Medical Equipment Industry Average Movement | 5.5% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: EI9 has not had significant price volatility in the past 3 months.
Volatility Over Time: EI9's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1923 | 653 | Stefano Alfonsi | elosmedtech.com |
Elos Medtech AB (publ) engages in the development and contract manufacturing of medical devices and components for dental, orthopedics, diagnostics, and hearing and other medical device markets. It offers implants, screws, plates, orthopedic and dental instruments, drills, pins and wires, dental prosthetics, disposable plastic products, HPLC fittings, and other medical plastic parts. The company also provides design and development, regulatory, prototyping, testing, OEM, process validation, and supply and inventory management, as well as design for manufacturing and engineering services.
Elos Medtech AB (publ) Fundamentals Summary
| EI9 fundamental statistics | |
|---|---|
| Market cap | €514.15m |
| Earnings (TTM) | €4.93m |
| Revenue (TTM) | €91.28m |
104.3x
P/E Ratio5.6x
P/S RatioIs EI9 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EI9 income statement (TTM) | |
|---|---|
| Revenue | SEK 1.02b |
| Cost of Revenue | SEK 676.62m |
| Gross Profit | SEK 341.02m |
| Other Expenses | SEK 286.07m |
| Earnings | SEK 54.95m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Feb 29, 2024
| Earnings per share (EPS) | 1.95 |
| Gross Margin | 33.51% |
| Net Profit Margin | 5.40% |
| Debt/Equity Ratio | 51.6% |
How did EI9 perform over the long term?
See historical performance and comparison